-
1
-
-
0037122736
-
Design of biodegradable particles for protein delivery
-
Vila, A., Sanchez, A., Tobio, M., Calvo, P. Design of biodegradable particles for protein delivery. J. Control. Release 78, 15-24 (2002).
-
(2002)
J. Control. Release
, vol.78
, pp. 15-24
-
-
Vila, A.1
Sanchez, A.2
Tobio, M.3
Calvo, P.4
-
2
-
-
0015492624
-
Gene therapy for human genetic disease
-
Friedmann, T., Roblin, R. Gene therapy for human genetic disease Science 175, 949-955 (1972).
-
(1972)
Science
, vol.175
, pp. 949-955
-
-
Friedmann, T.1
Roblin, R.2
-
3
-
-
84958963329
-
Gene therapy for X-linked severe combined immunodeficiency: Where do we stand
-
Cavazzana, M., Six, E., Lagresle-Peyrou, C., André-Schmutz, I., Hacein-Bey-Abina, S. Gene therapy for X-linked severe combined immunodeficiency: Where do we stand Hum. Gene Ther. 27, 108-116 (2016).
-
(2016)
Hum. Gene Ther.
, vol.27
, pp. 108-116
-
-
Cavazzana, M.1
Six, E.2
Lagresle-Peyrou, C.3
André-Schmutz, I.4
Hacein-Bey-Abina, S.5
-
4
-
-
84921794613
-
mRNA-based therapeutics-developing a new class of drugs
-
Sahin, U., Kariko, K., Türeci, Ö. mRNA-based therapeutics-developing a new class of drugs. Nat. Rev. Drug Discov. 13, 759-780 (2014).
-
(2014)
Nat. Rev. Drug Discov.
, vol.13
, pp. 759-780
-
-
Sahin, U.1
Kariko, K.2
Türeci, O.3
-
5
-
-
0027170483
-
Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA
-
Martinon, F., et al. Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA. Eur. J. Immunol. 23, 1719-1722 (1993).
-
(1993)
Eur. J. Immunol.
, vol.23
, pp. 1719-1722
-
-
Martinon, F.1
-
6
-
-
0028965192
-
Characterization of a messenger RNA polynucleotide vaccine vector
-
Conry, R., LoBuglio, A., Wright, M., Sumerel, L. Characterization of a messenger RNA polynucleotide vaccine vector. Cancer Res. 55, 1397-1400 (1995).
-
(1995)
Cancer Res.
, vol.55
, pp. 1397-1400
-
-
Conry, R.1
LoBuglio, A.2
Wright, M.3
Sumerel, L.4
-
7
-
-
84949637138
-
An orthogonal array optimization of lipid-like nanoparticles for mRNA delivery in vivo
-
Li, B., et al. An orthogonal array optimization of lipid-like nanoparticles for mRNA delivery in vivo. Nano Lett. 15, 8099-8107 (2015).
-
(2015)
Nano Lett.
, vol.15
, pp. 8099-8107
-
-
Li, B.1
-
8
-
-
84976580479
-
Therapeutic efficacy in a hemophilia B model using a biosynthetic mRNA liver depot system
-
DeRosa, F., et al. Therapeutic efficacy in a hemophilia B model using a biosynthetic mRNA liver depot system. Gene Ther. 23, 699-707 (2016).
-
(2016)
Gene Ther.
, vol.23
, pp. 699-707
-
-
DeRosa, F.1
-
9
-
-
85014634181
-
Systemic delivery of factor IX messenger RNA for protein replacement therapy
-
Ramaswamy, S., et al. Systemic delivery of factor IX messenger RNA for protein replacement therapy. Proc. Natl Acad. Sci. USA 114, E1941-E1950 (2017).
-
(2017)
Proc. Natl Acad. Sci. USA
, vol.114
, pp. E1941-E1950
-
-
Ramaswamy, S.1
-
10
-
-
84885676364
-
Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction
-
Zangi, L., et al. Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction. Nat. Biotechnol. 31, 898-907 (2013).
-
(2013)
Nat. Biotechnol.
, vol.31
, pp. 898-907
-
-
Zangi, L.1
-
11
-
-
84991660875
-
Induction of HIV-1 gag specific immune responses by cationic micelles mediated delivery of gag mRNA
-
Zhao, M., Li, M., Zhang, Z., Gong, T., Sun, X. Induction of HIV-1 gag specific immune responses by cationic micelles mediated delivery of gag mRNA. Drug Deliv. 23, 2596-2607 (2016).
-
(2016)
Drug Deliv.
, vol.23
, pp. 2596-2607
-
-
Zhao, M.1
Li, M.2
Zhang, Z.3
Gong, T.4
Sun, X.5
-
12
-
-
85014176711
-
Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge
-
Pardi, N., et al. Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge. Nat. Commun. 8, 14630 (2017).
-
(2017)
Nat. Commun.
, vol.8
, pp. 14630
-
-
Pardi, N.1
-
13
-
-
85014758993
-
Lipid nanoparticle assisted mRNA delivery for potent cancer immunotherapy
-
Oberli, M. A., et al. Lipid nanoparticle assisted mRNA delivery for potent cancer immunotherapy. Nano Lett. 17, 1326-1335 (2016).
-
(2016)
Nano Lett.
, vol.17
, pp. 1326-1335
-
-
Oberli, M.A.1
-
14
-
-
84957561169
-
Systemic delivery of messenger RNA for the treatment of pancreatic cancer using polyplex nanomicelles with a cholesterol moiety
-
Uchida, S., et al. Systemic delivery of messenger RNA for the treatment of pancreatic cancer using polyplex nanomicelles with a cholesterol moiety. Biomaterials 82, 221-228 (2016).
-
(2016)
Biomaterials
, vol.82
, pp. 221-228
-
-
Uchida, S.1
-
15
-
-
85015248929
-
Particle-mediated intravenous delivery of antigen mRNA results in strong antigen-specific T cell responses despite the induction of type I interferon
-
Broos, K., et al. Particle-mediated intravenous delivery of antigen mRNA results in strong antigen-specific T cell responses despite the induction of type I interferon. Mol. Ther. Nucleic Acids 5, e326 (2016).
-
(2016)
Mol. Ther. Nucleic Acids
, vol.5
, pp. e326
-
-
Broos, K.1
-
17
-
-
0032977685
-
Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy
-
Bonne, G., et al. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat. Genet. 21, 285-288 (1999).
-
(1999)
Nat. Genet.
, vol.21
, pp. 285-288
-
-
Bonne, G.1
-
18
-
-
70449209123
-
On protein synthesis
-
Crick, F. On protein synthesis. Symp. Soc. Exp. Biol. 12, 138-163 (1958).
-
(1958)
Symp. Soc. Exp. Biol.
, vol.12
, pp. 138-163
-
-
Crick, F.1
-
19
-
-
0001498120
-
A multiple ribosomal structure in protein synthesis
-
Warner, J., Knopf, P., Rich, A. A multiple ribosomal structure in protein synthesis. Proc. Natl Acad. Sci. USA 49, 122-129 (1963).
-
(1963)
Proc. Natl Acad. Sci. USA
, vol.49
, pp. 122-129
-
-
Warner, J.1
Knopf, P.2
Rich, A.3
-
20
-
-
0025231388
-
Direct gene transfer into mouse muscle in vivo
-
Wolff, J. A., et al. Direct gene transfer into mouse muscle in vivo. Science 247, 1465-1468 (1990).
-
(1990)
Science
, vol.247
, pp. 1465-1468
-
-
Wolff, J.A.1
-
21
-
-
0026522713
-
Reversal of diabetes insipidus in Brattleboro rats: Intrathypothalmic injection of vasopressin mRNA
-
Jirikowski, G., Sanna, P. P., Maciejewski-Lenoir, D., Bloom, F. Reversal of diabetes insipidus in Brattleboro rats: Intrathypothalmic injection of vasopressin mRNA. Science 255, 996-998 (1992).
-
(1992)
Science
, vol.255
, pp. 996-998
-
-
Jirikowski, G.1
Sanna, P.P.2
MacIejewski-Lenoir, D.3
Bloom, F.4
-
22
-
-
19544380240
-
Protein glycosylation: New challenges and opportunities
-
Wong, C.-H. Protein glycosylation: New challenges and opportunities. J. Org. Chem. 70, 4219-4225 (2005).
-
(2005)
J. Org. Chem.
, vol.70
, pp. 4219-4225
-
-
Wong, C.-H.1
-
23
-
-
84910679144
-
Proteome-wide post-translational modification statistics: Frequency analysis and curation of the swiss-prot database
-
Khoury, G. A., Baliban, R. C., Floudas, C. A. Proteome-wide post-translational modification statistics: Frequency analysis and curation of the swiss-prot database. Sci. Rep. 1, 90 (2011).
-
(2011)
Sci. Rep.
, vol.1
, pp. 90
-
-
Khoury, G.A.1
Baliban, R.C.2
Floudas, C.A.3
-
24
-
-
84870886906
-
Developing mRNA-vaccine technologies
-
Schlake, T., Thess, A., Fotin-Mleczek, M., Kallen, K.-J. Developing mRNA-vaccine technologies. RNA Biol. 9, 1319-1330 (2012).
-
(2012)
RNA Biol.
, vol.9
, pp. 1319-1330
-
-
Schlake, T.1
Thess, A.2
Fotin-Mleczek, M.3
Kallen, K.-J.4
-
25
-
-
84921357504
-
Lipid-based mRNA vaccine delivery systems
-
Midoux, P., Pichon, C. Lipid-based mRNA vaccine delivery systems. Expert Rev. Vaccines 14, 221-234 (2015).
-
(2015)
Expert Rev. Vaccines
, vol.14
, pp. 221-234
-
-
Midoux, P.1
Pichon, C.2
-
26
-
-
84901249588
-
Nucleic acid vaccines: Prospects for non-viral delivery of mRNA vaccines
-
Deering, R. P., Kommareddy, S., Ulmer, J. B., Brito, L. A., Geall, A. J. Nucleic acid vaccines: Prospects for non-viral delivery of mRNA vaccines. Expert Opin. Drug Deliv. 11, 885-899 (2014).
-
(2014)
Expert Opin. Drug Deliv.
, vol.11
, pp. 885-899
-
-
Deering, R.P.1
Kommareddy, S.2
Ulmer, J.B.3
Brito, L.A.4
Geall, A.J.5
-
27
-
-
84901368457
-
The origins and functions of dendritic cells and macrophages in the skin
-
Malissen, B., Tamoutounour, S., Henri, S. The origins and functions of dendritic cells and macrophages in the skin. Nat. Rev. Immunol. 14, 417-428 (2014).
-
(2014)
Nat. Rev. Immunol.
, vol.14
, pp. 417-428
-
-
Malissen, B.1
Tamoutounour, S.2
Henri, S.3
-
28
-
-
84856826706
-
CD64 expression distinguishes monocyte-derived and conventional dendritic cells and reveals their distinct role during intramuscular immunization
-
Langlet, C., et al. CD64 expression distinguishes monocyte-derived and conventional dendritic cells and reveals their distinct role during intramuscular immunization. J. Immunol. 188, 1751-1760 (2012).
-
(2012)
J. Immunol.
, vol.188
, pp. 1751-1760
-
-
Langlet, C.1
-
29
-
-
0033826798
-
Induction of cytotoxic T cell responses and tumour immunity against unrelated tumours using telomerase reverse transcriptase RNA transfected dendritic cells
-
Nair, S., Heiser, A., Boczkowski, D., Majumdar, A. Induction of cytotoxic T cell responses and tumour immunity against unrelated tumours using telomerase reverse transcriptase RNA transfected dendritic cells. Nat. Med. 6, 1011-1017 (2000).
-
(2000)
Nat. Med.
, vol.6
, pp. 1011-1017
-
-
Nair, S.1
Heiser, A.2
Boczkowski, D.3
Majumdar, A.4
-
30
-
-
79960725328
-
Enhancement of dendritic cells transfection in vivo and of vaccination against B16F10 melanoma with mannosylated histidylated lipopolyplexes loaded with tumour antigen messenger RNA
-
Perche, F., et al. Enhancement of dendritic cells transfection in vivo and of vaccination against B16F10 melanoma with mannosylated histidylated lipopolyplexes loaded with tumour antigen messenger RNA. Nanomedicine 7, 445-453 (2011).
-
(2011)
Nanomedicine
, vol.7
, pp. 445-453
-
-
Perche, F.1
-
31
-
-
0035251532
-
Functional expression of chimeric receptor genes in human T cells
-
Eshhar, Z., Waks, T., Bendavid, A., Schindler, D. Functional expression of chimeric receptor genes in human T cells. J. Immunol. Methods 248, 67-76 (2001).
-
(2001)
J. Immunol. Methods
, vol.248
, pp. 67-76
-
-
Eshhar, Z.1
Waks, T.2
Bendavid, A.3
Schindler, D.4
-
32
-
-
84880733312
-
Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology
-
Kalos, M., June, C. H. Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology. Immunity 39, 49-60 (2013).
-
(2013)
Immunity
, vol.39
, pp. 49-60
-
-
Kalos, M.1
June, C.H.2
-
33
-
-
84887471195
-
Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T Cells in glioblastoma
-
Hegde, M., et al. Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T Cells in glioblastoma. Mol. Ther. 21, 2087-2101 (2013).
-
(2013)
Mol. Ther.
, vol.21
, pp. 2087-2101
-
-
Hegde, M.1
-
34
-
-
83455213653
-
Treatment of advanced leukemia in mice with mRNA engineered T cells
-
Barrett, D. M., et al. Treatment of advanced leukemia in mice with mRNA engineered T cells. Hum. Gene Ther. 22, 1575-1586 (2011).
-
(2011)
Hum. Gene Ther.
, vol.22
, pp. 1575-1586
-
-
Barrett, D.M.1
-
35
-
-
84882410441
-
Regimen-specific effects of RNA-modified chimeric antigen receptor T cells in mice with advanced leukemia
-
Barrett, D. M., et al. Regimen-specific effects of RNA-modified chimeric antigen receptor T cells in mice with advanced leukemia. Hum. Gene Ther. 24, 717-727 (2013).
-
(2013)
Hum. Gene Ther.
, vol.24
, pp. 717-727
-
-
Barrett, D.M.1
-
36
-
-
84857097177
-
RNA-guided genetic silencing systems in bacteria and archaea
-
Wiedenheft, B., Sternberg, S. H., Doudna, J. A. RNA-guided genetic silencing systems in bacteria and archaea. Nature 482, 331-338 (2012).
-
(2012)
Nature
, vol.482
, pp. 331-338
-
-
Wiedenheft, B.1
Sternberg, S.H.2
Doudna, J.A.3
-
37
-
-
84913594397
-
The new frontier of genome engineering with CRISPR-Cas9
-
Doudna, J. A., Charpentier, E. The new frontier of genome engineering with CRISPR-Cas9. Science 346, 1258096 (2014).
-
(2014)
Science
, vol.346
, pp. 1258096
-
-
Doudna, J.A.1
Charpentier, E.2
-
38
-
-
84873729095
-
Multiplex genome engineering using CRISPR/Cas systems
-
Cong, L., et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819-823 (2013).
-
(2013)
Science
, vol.339
, pp. 819-823
-
-
Cong, L.1
-
39
-
-
84902096048
-
Development and applications of CRISPR-Cas9 for genome engineering
-
Hsu, P. D., Lander, E. S., Zhang, F. Development and applications of CRISPR-Cas9 for genome engineering. Cell 157, 1262-1278 (2014).
-
(2014)
Cell
, vol.157
, pp. 1262-1278
-
-
Hsu, P.D.1
Lander, E.S.2
Zhang, F.3
-
40
-
-
84923266604
-
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
-
Tsai, S. Q., et al. GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat. Biotechnol. 33, 187-197 (2015).
-
(2015)
Nat. Biotechnol.
, vol.33
, pp. 187-197
-
-
Tsai, S.Q.1
-
41
-
-
84975678715
-
Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system
-
Zetsche, B., et al. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell 163, 759-771 (2015).
-
(2015)
Cell
, vol.163
, pp. 759-771
-
-
Zetsche, B.1
-
42
-
-
84981356862
-
Generation of knockout mice by Cpf1-mediated gene targeting
-
Kim, Y., et al. Generation of knockout mice by Cpf1-mediated gene targeting. Nat. Biotechnol. 34, 808-810 (2016).
-
(2016)
Nat. Biotechnol.
, vol.34
, pp. 808-810
-
-
Kim, Y.1
-
43
-
-
85001073672
-
CRISPR-Cas9-mediated multiplex gene editing in CAR-T cells
-
Liu, X., et al. CRISPR-Cas9-mediated multiplex gene editing in CAR-T cells. Cell Res. 27, 154-157 (2016).
-
(2016)
Cell Res.
, vol.27
, pp. 154-157
-
-
Liu, X.1
-
44
-
-
85018387101
-
Multiplex genome editing to generate universal CAR T Cells resistant to PD1 inhibition
-
Ren, J., et al. Multiplex genome editing to generate universal CAR T Cells resistant to PD1 inhibition. Clin. Cancer Res. 23, 2255-2266 (2017).
-
(2017)
Clin. Cancer Res.
, vol.23
, pp. 2255-2266
-
-
Ren, J.1
-
45
-
-
85018998407
-
CRISPR-Cas9-mediated PD-1 disruption enhances anti-tumour efficacy of human chimeric antigen receptor T cells
-
Rupp, L. J., et al. CRISPR-Cas9-mediated PD-1 disruption enhances anti-tumour efficacy of human chimeric antigen receptor T cells. Sci. Rep. 7, 737 (2017).
-
(2017)
Sci. Rep.
, vol.7
, pp. 737
-
-
Rupp, L.J.1
-
46
-
-
85014564234
-
Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
-
Eyquem, J., et al. Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection. Nature 543, 113-117 (2017).
-
(2017)
Nature
, vol.543
, pp. 113-117
-
-
Eyquem, J.1
-
47
-
-
33747195353
-
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
-
Takahashi, K., Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676 (2006).
-
(2006)
Cell
, vol.126
, pp. 663-676
-
-
Takahashi, K.1
Yamanaka, S.2
-
48
-
-
77958536106
-
Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA
-
Warren, L., et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7, 618-630 (2010).
-
(2010)
Cell Stem Cell
, vol.7
, pp. 618-630
-
-
Warren, L.1
-
49
-
-
84875160871
-
Reprogramming human fibroblasts to pluripotency using modified mRNA
-
Mandal, P. K., Rossi, D. J. Reprogramming human fibroblasts to pluripotency using modified mRNA. Nat. Protoc. 8, 568-582 (2013).
-
(2013)
Nat. Protoc.
, vol.8
, pp. 568-582
-
-
Mandal, P.K.1
Rossi, D.J.2
-
50
-
-
9144252038
-
Complete sequencing and characterization of 21, 243 full-length human cDNAs
-
Ota, T., et al. Complete sequencing and characterization of 21, 243 full-length human cDNAs. Nat. Genet. 36, 40-45 (2004).
-
(2004)
Nat. Genet.
, vol.36
, pp. 40-45
-
-
Ota, T.1
-
51
-
-
0017224213
-
Capping of eucaryotic mRNAs
-
Shatkin, A. J. Capping of eucaryotic mRNAs. Cell 9, 645-653 (1976).
-
(1976)
Cell
, vol.9
, pp. 645-653
-
-
Shatkin, A.J.1
-
52
-
-
0035476704
-
The major mRNA-associated protein YB-1 is a potent 5 cap-dependent mRNA stabilizer
-
Evdokimova, V., Ruzanov, P., Imataka, H., Raught, B., Svitkin, Y. The major mRNA-associated protein YB-1 is a potent 5 cap-dependent mRNA stabilizer. EMBO J. 20, 5491-5502 (2001).
-
(2001)
EMBO J.
, vol.20
, pp. 5491-5502
-
-
Evdokimova, V.1
Ruzanov, P.2
Imataka, H.3
Raught, B.4
Svitkin, Y.5
-
53
-
-
0030832026
-
EIF4G dramatically enhances the binding of eIF4E to the mRNA 5-cap structure
-
Haghighat, A., Sonenberg, N. eIF4G dramatically enhances the binding of eIF4E to the mRNA 5-cap structure. J. Biol. Chem. 272, 21677-21680 (1997).
-
(1997)
J. Biol. Chem.
, vol.272
, pp. 21677-21680
-
-
Haghighat, A.1
Sonenberg, N.2
-
54
-
-
84896405087
-
TAIL-seq: Genome-wide determination of poly(A) tail length and 3 end modifications
-
Chang, H., Lim, J., Ha, M., Kim, V. N. TAIL-seq: Genome-wide determination of poly(A) tail length and 3 end modifications. Mol. Cell 53, 1044-1052 (2014).
-
(2014)
Mol. Cell
, vol.53
, pp. 1044-1052
-
-
Chang, H.1
Lim, J.2
Ha, M.3
Kim, V.N.4
-
55
-
-
0035819859
-
Regulation of mRNA stability in mammalian cells
-
Guhaniyogi, J., Brewer, G. Regulation of mRNA stability in mammalian cells. Gene 265, 11-23 (2001).
-
(2001)
Gene
, vol.265
, pp. 11-23
-
-
Guhaniyogi, J.1
Brewer, G.2
-
56
-
-
36148973188
-
A novel method for poly(A) fractionation reveals a large population of mRNAs with a short poly(A) tail in mammalian cells
-
Meijer, H. A., et al. A novel method for poly(A) fractionation reveals a large population of mRNAs with a short poly(A) tail in mammalian cells. Nucleic Acids Res. 35, e132 (2007).
-
(2007)
Nucleic Acids Res.
, vol.35
, pp. e132
-
-
Meijer, H.A.1
-
57
-
-
33845497677
-
Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells
-
Holtkamp, S., et al. Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells. Blood 108, 4009-4017 (2006).
-
(2006)
Blood
, vol.108
, pp. 4009-4017
-
-
Holtkamp, S.1
-
58
-
-
0036207282
-
Untranslated regions of mRNAs
-
reviews0004-1
-
Mignone, F., Gissi, C., Liuni, S., Pesole, G. Untranslated regions of mRNAs. Genome Biol. 3, reviews0004-1 (2002).
-
(2002)
Genome Biol.
, vol.3
-
-
Mignone, F.1
Gissi, C.2
Liuni, S.3
Pesole, G.4
-
59
-
-
0028788194
-
AU-rich elements: Characterization and importance in mRNA degradation
-
Chen, C.-Y., Shyu, A.-B. AU-rich elements: Characterization and importance in mRNA degradation. Trends Biochem. Sci. 20, 465-470 (1995).
-
(1995)
Trends Biochem. Sci.
, vol.20
, pp. 465-470
-
-
Chen, C.-Y.1
Shyu, A.-B.2
-
60
-
-
0033022244
-
Overexpression of urokinase receptor in mammalian cells following administration of the in vitro transcribed encoding mRNA
-
Kariko, K., Kuo, A., Barnathan, E. S. Overexpression of urokinase receptor in mammalian cells following administration of the in vitro transcribed encoding mRNA. Gene Ther. 6, 1092-1100 (1999).
-
(1999)
Gene Ther.
, vol.6
, pp. 1092-1100
-
-
Kariko, K.1
Kuo, A.2
Barnathan, E.S.3
-
61
-
-
79960107932
-
Protein expression from exogenous mRNA: Uptake by receptor-mediated endocytosis and trafficking via the lysosomal pathway
-
Lorenz, C., et al. Protein expression from exogenous mRNA: Uptake by receptor-mediated endocytosis and trafficking via the lysosomal pathway. RNA Biol. 8, 627-636 (2011).
-
(2011)
RNA Biol.
, vol.8
, pp. 627-636
-
-
Lorenz, C.1
-
62
-
-
33750976374
-
5-Triphosphate RNA Is the ligand for RIG-I
-
Hornung, V., Ellegast, J., Kim, S., Brzozka, K., Jung, A. 5-Triphosphate RNA Is the ligand for RIG-I. Science 314, 994-997 (2006).
-
(2006)
Science
, vol.314
, pp. 994-997
-
-
Hornung, V.1
Ellegast, J.2
Kim, S.3
Brzozka, K.4
Jung, A.5
-
63
-
-
79956314622
-
Immune signaling by RIG-I-like receptors
-
Loo, Y.-M., Gale, M. Jr. Immune signaling by RIG-I-like receptors. Immunity 34, 680-692 (2011).
-
(2011)
Immunity
, vol.34
, pp. 680-692
-
-
Loo, Y.-M.1
Gale, M.2
-
64
-
-
1542317550
-
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
-
Diebold, S., Kaisho, T., Hemmi, H., Akira, S., Sousa, C. R. E. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303, 1529-1531 (2004).
-
(2004)
Science
, vol.303
, pp. 1529-1531
-
-
Diebold, S.1
Kaisho, T.2
Hemmi, H.3
Akira, S.4
Sousa, C.R.E.5
-
65
-
-
1542317578
-
Species-specific recognition of single-stranded RNA via Toll-like receptor 7 and 8
-
Heil, F., Hemmi, H., Hochrein, H., Ampenberger, F., Kirschning, C. Species-specific recognition of single-stranded RNA via Toll-like receptor 7 and 8. Science 303, 1526-1529 (2004).
-
(2004)
Science
, vol.303
, pp. 1526-1529
-
-
Heil, F.1
Hemmi, H.2
Hochrein, H.3
Ampenberger, F.4
Kirschning, C.5
-
66
-
-
84901446294
-
Trafficking of endosomal Toll-like receptors
-
Lee, B. L., Barton, G. M. Trafficking of endosomal Toll-like receptors. Trends Cell Biol. 24, 360-369 (2014).
-
(2014)
Trends Cell Biol.
, vol.24
, pp. 360-369
-
-
Lee, B.L.1
Barton, G.M.2
-
67
-
-
34548431318
-
Naturally occurring nucleoside modifications suppress the immunostimulatory activity of RNA: Implications for therapeutic RNA development
-
Kariko, K., Weissman, D. Naturally occurring nucleoside modifications suppress the immunostimulatory activity of RNA: Implications for therapeutic RNA development. Curr. Opin. Drug Discov. Devel. 10, 523-532 (2007).
-
(2007)
Curr. Opin. Drug Discov. Devel.
, vol.10
, pp. 523-532
-
-
Kariko, K.1
Weissman, D.2
-
68
-
-
84975477667
-
Epigenetic mechanisms in neurogenesis
-
Yao, B., et al. Epigenetic mechanisms in neurogenesis. Nat. Rev. Neurosci. 17, 537-549 (2016).
-
(2016)
Nat. Rev. Neurosci.
, vol.17
, pp. 537-549
-
-
Yao, B.1
-
69
-
-
23844464444
-
Suppression of RNA recognition by toll-like receptors: The impact of nucleoside modification and the evolutionary origin of RNA
-
Kariko, K., Buckstein, M., Ni, H., Weissman, D. Suppression of RNA recognition by toll-like receptors: The impact of nucleoside modification and the evolutionary origin of RNA. Immunity 23, 165-175 (2005).
-
(2005)
Immunity
, vol.23
, pp. 165-175
-
-
Kariko, K.1
Buckstein, M.2
Ni, H.3
Weissman, D.4
-
70
-
-
54949112814
-
Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability
-
Kariko, K., et al. Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Mol. Ther. 16, 1833-1840 (2008).
-
(2008)
Mol. Ther.
, vol.16
, pp. 1833-1840
-
-
Kariko, K.1
-
71
-
-
77957242130
-
Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation
-
Anderson, B. R., et al. Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation. Nucleic Acids Res. 38, 5884-5892 (2010).
-
(2010)
Nucleic Acids Res.
, vol.38
, pp. 5884-5892
-
-
Anderson, B.R.1
-
72
-
-
79751497093
-
Expression of therapeutic proteins after delivery of chemically modified mRNA in mice
-
Kormann, M. S. D., et al. Expression of therapeutic proteins after delivery of chemically modified mRNA in mice. Nat. Biotechnol. 29, 154-157 (2011).
-
(2011)
Nat. Biotechnol.
, vol.29
, pp. 154-157
-
-
Kormann, M.S.D.1
-
73
-
-
84860539841
-
Increased erythropoiesis in mice injected with submicrogram quantities of pseudouridine-containing mRNA encoding erythropoietin
-
Kariko, K., Muramatsu, H., Keller, J. M., Weissman, D. Increased erythropoiesis in mice injected with submicrogram quantities of pseudouridine-containing mRNA encoding erythropoietin. Mol. Ther. 20, 948-953 (2012).
-
(2012)
Mol. Ther.
, vol.20
, pp. 948-953
-
-
Kariko, K.1
Muramatsu, H.2
Keller, J.M.3
Weissman, D.4
-
74
-
-
84945455309
-
N1-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice
-
Andries, O., et al. N1-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice. J. Control. Release 217, 337-344 (2015).
-
(2015)
J. Control. Release
, vol.217
, pp. 337-344
-
-
Andries, O.1
-
75
-
-
82255194361
-
Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA
-
Kariko, K., Muramatsu, H., Ludwig, J., Weissman, D. Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA. Nucleic Acids Res. 39, e142 (2011).
-
(2011)
Nucleic Acids Res.
, vol.39
, pp. e142
-
-
Kariko, K.1
Muramatsu, H.2
Ludwig, J.3
Weissman, D.4
-
76
-
-
65249141709
-
Database for mRNA half-life of 19, 977 genes obtained by DNA microarray analysis of pluripotent and differentiating mouse embryonic stem cells
-
Sharova, L. V., et al. Database for mRNA half-life of 19, 977 genes obtained by DNA microarray analysis of pluripotent and differentiating mouse embryonic stem cells. DNA Res. 16, 45-58 (2008).
-
(2008)
DNA Res.
, vol.16
, pp. 45-58
-
-
Sharova, L.V.1
-
77
-
-
60149090021
-
The many pathways of RNA degradation
-
Houseley, J., Tollervey, D. The many pathways of RNA degradation. Cell 136, 763-776 (2009).
-
(2009)
Cell
, vol.136
, pp. 763-776
-
-
Houseley, J.1
Tollervey, D.2
-
78
-
-
0020339802
-
Gene transfer into mouse lyoma cells by electroporation in high electric fields
-
Neumann, E., Schaefer-Ridder, M., Wang, Y., Hofschneider, P. H. Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J. 1, 841-845 (1982).
-
(1982)
EMBO J.
, vol.1
, pp. 841-845
-
-
Neumann, E.1
Schaefer-Ridder, M.2
Wang, Y.3
Hofschneider, P.H.4
-
79
-
-
8844253952
-
RNA-based gene transfer for adult stem cells and T cells
-
Smits, E., et al. RNA-based gene transfer for adult stem cells and T cells. Leukemia 18, 1898-1902 (2004).
-
(2004)
Leukemia
, vol.18
, pp. 1898-1902
-
-
Smits, E.1
-
80
-
-
0035412401
-
Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: Superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumour antigen loading of dendritic cells
-
Van Tendeloo, V. F. I. Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: Superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumour antigen loading of dendritic cells. Blood 98, 49-56 (2001).
-
(2001)
Blood
, vol.98
, pp. 49-56
-
-
Van Tendeloo, V.F.I.1
-
81
-
-
84931274702
-
Electroporation enables the efficient mRNA delivery into the mouse zygotes and facilitates CRISPR/Cas9-based genome editing
-
Hashimoto, M., Takemoto, T. Electroporation enables the efficient mRNA delivery into the mouse zygotes and facilitates CRISPR/Cas9-based genome editing. Sci. Rep. 5, 11315 (2015).
-
(2015)
Sci. Rep.
, vol.5
, pp. 11315
-
-
Hashimoto, M.1
Takemoto, T.2
-
82
-
-
0023244634
-
High-velocity microprojectiles for delivering nucleic acids into living cells
-
Klein, T. M., Wolf, E. D., Wu, R., Sanford, J. C. High-velocity microprojectiles for delivering nucleic acids into living cells. Nature 327, 70-73 (1987).
-
(1987)
Nature
, vol.327
, pp. 70-73
-
-
Klein, T.M.1
Wolf, E.D.2
Wu, R.3
Sanford, J.C.4
-
83
-
-
0029875845
-
Gene gun delivery of mRNA in situ results in efficient transgene and genetic immunization
-
Qiu, P., Ziegelhoffer, P., Sun, J., Yang, N. S. Gene gun delivery of mRNA in situ results in efficient transgene and genetic immunization. Gene Ther. 3, 262-268 (1996).
-
(1996)
Gene Ther.
, vol.3
, pp. 262-268
-
-
Qiu, P.1
Ziegelhoffer, P.2
Sun, J.3
Yang, N.S.4
-
84
-
-
0031787197
-
In vitro-synthesized infectious RNA as an attenuated live vaccine in a flavivirus model
-
Mandl, C. W., et al. In vitro-synthesized infectious RNA as an attenuated live vaccine in a flavivirus model. Nat. Med. 4, 1438-1440 (1998).
-
(1998)
Nat. Med.
, vol.4
, pp. 1438-1440
-
-
Mandl, C.W.1
-
86
-
-
84255193135
-
Design of multifunctional non-viral gene vectors to overcome physiological barriers: Dilemmas and strategies
-
Wang, T., Upponi, J. R., Torchilin, V. P. Design of multifunctional non-viral gene vectors to overcome physiological barriers: Dilemmas and strategies. Int. J. Pharm. 427, 3-20 (2012).
-
(2012)
Int. J. Pharm.
, vol.427
, pp. 3-20
-
-
Wang, T.1
Upponi, J.R.2
Torchilin, V.P.3
-
87
-
-
71749093911
-
Immunize and disappear-safety-optimized mRNA vaccination with a panel of 29 allergens
-
Roesler, E., et al. Immunize and disappear-safety-optimized mRNA vaccination with a panel of 29 allergens. J. Allergy Clin. Immunol. 124, 1070-1077 (2009).
-
(2009)
J. Allergy Clin. Immunol.
, vol.124
, pp. 1070-1077
-
-
Roesler, E.1
-
88
-
-
84870869040
-
Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection
-
Petsch, B., et al. Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection. Nat. Biotechnol 30, 1210-1216 (2012).
-
(2012)
Nat. Biotechnol
, vol.30
, pp. 1210-1216
-
-
Petsch, B.1
-
89
-
-
84947087001
-
Prophylactic mRNA vaccination against allergy confers long-term memory responses and persistent protection in mice
-
Hattinger, E., et al. Prophylactic mRNA vaccination against allergy confers long-term memory responses and persistent protection in mice. J. Immunol. Res. 2015, 797421 (2015).
-
(2015)
J. Immunol. Res.
, vol.2015
, pp. 797421
-
-
Hattinger, E.1
-
90
-
-
59349116903
-
Knocking down barriers; Advances in siRNA delivery
-
Whitehead, K. A., Langer, R., Anderson, D. G. Knocking down barriers; advances in siRNA delivery. Nat. Rev. Drug Discov. 8, 129-138 (2009).
-
(2009)
Nat. Rev. Drug Discov.
, vol.8
, pp. 129-138
-
-
Whitehead, K.A.1
Langer, R.2
Anderson, D.G.3
-
91
-
-
84904544984
-
Non-viral vectors for gene-based therapy
-
Yin, H., et al. Non-viral vectors for gene-based therapy. Nat. Rev. Genet. 15, 541-555 (2014).
-
(2014)
Nat. Rev. Genet.
, vol.15
, pp. 541-555
-
-
Yin, H.1
-
92
-
-
51049092308
-
Factors affecting the clearance and biodistribution of polymeric nanoparticles
-
Alexis, F., Pridgen, E., Molnar, L. K., Farokhzad, O. C. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol. Pharm. 5, 505-515 (2008).
-
(2008)
Mol. Pharm.
, vol.5
, pp. 505-515
-
-
Alexis, F.1
Pridgen, E.2
Molnar, L.K.3
Farokhzad, O.C.4
-
93
-
-
4344618969
-
Extracellular matrix glycoproteins and diffusion barriers in human astrocytic tumours
-
Zamecnik, J., Vargova, L., Homola, A., Kodet, R., Sykova, E. Extracellular matrix glycoproteins and diffusion barriers in human astrocytic tumours. Neuropathol. Appl. Neurobiol. 30, 338-350 (2004).
-
(2004)
Neuropathol. Appl. Neurobiol.
, vol.30
, pp. 338-350
-
-
Zamecnik, J.1
Vargova, L.2
Homola, A.3
Kodet, R.4
Sykova, E.5
-
94
-
-
84938898581
-
Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown
-
Wittrup, A., et al. Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown. Nat. Biotechnol. 33, 870-876 (2015).
-
(2015)
Nat. Biotechnol.
, vol.33
, pp. 870-876
-
-
Wittrup, A.1
-
95
-
-
84880304273
-
Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape
-
Gilleron, J., et al. Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape. Nat. Biotechnol. 31, 638-646 (2013).
-
(2013)
Nat. Biotechnol.
, vol.31
, pp. 638-646
-
-
Gilleron, J.1
-
96
-
-
84862704697
-
Virus-mediated gene delivery for human gene therapy
-
Giacca, M., Zacchigna, S. Virus-mediated gene delivery for human gene therapy. J. Control. Release 161, 377-388 (2012).
-
(2012)
J. Control. Release
, vol.161
, pp. 377-388
-
-
Giacca, M.1
Zacchigna, S.2
-
97
-
-
0032578532
-
Site-specific gene delivery in vivo through engineered Sendai viral envelopes
-
Ramani, K., Hassan, Q., Venkaiah, B., Hasnain, S., Sarkar, D. Site-specific gene delivery in vivo through engineered Sendai viral envelopes. Proc. Natl Acad. Sci. USA 95, 11886-11890 (1998).
-
(1998)
Proc. Natl Acad. Sci. USA
, vol.95
, pp. 11886-11890
-
-
Ramani, K.1
Hassan, Q.2
Venkaiah, B.3
Hasnain, S.4
Sarkar, D.5
-
98
-
-
77949424429
-
Progress and prospects: Immune responses to viral vectors
-
Nayak, S., Herzog, R. W. Progress and prospects: Immune responses to viral vectors. Gene Ther. 17, 295-304 (2010).
-
(2010)
Gene Ther.
, vol.17
, pp. 295-304
-
-
Nayak, S.1
Herzog, R.W.2
-
99
-
-
85018490272
-
SiRNA delivery strategies: A comprehensive review of recent developments
-
Tatiparti, K., Sau, S., Kashaw, S., Iyer, A. siRNA delivery strategies: A comprehensive review of recent developments. Nanomaterials 7, 77 (2017).
-
(2017)
Nanomaterials
, vol.7
, pp. 77
-
-
Tatiparti, K.1
Sau, S.2
Kashaw, S.3
Iyer, A.4
-
100
-
-
14144250911
-
Recent advances with liposomes as pharmaceutical carriers
-
Torchilin, V. P. Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug Discov. 4, 145-160 (2005).
-
(2005)
Nat. Rev. Drug Discov.
, vol.4
, pp. 145-160
-
-
Torchilin, V.P.1
-
101
-
-
3142714019
-
Cationic liposome-mediated RNA transfection
-
Malone, R. W., Felgner, P. L., Verma, I. M. Cationic liposome-mediated RNA transfection. Proc. Natl Acad. Sci. USA 86, 6077-6081 (1989).
-
(1989)
Proc. Natl Acad. Sci. USA
, vol.86
, pp. 6077-6081
-
-
Malone, R.W.1
Felgner, P.L.2
Verma, I.M.3
-
102
-
-
0037429077
-
Stability of mRNA/cationic lipid lipoplexes in human and rat cerebrospinal fluid: Methods and evidence for nonviral mRNA gene delivery to the central nervous system
-
Anderson, D. M., et al. Stability of mRNA/cationic lipid lipoplexes in human and rat cerebrospinal fluid: Methods and evidence for nonviral mRNA gene delivery to the central nervous system. Hum. Gene Ther. 14, 191-202 (2003).
-
(2003)
Hum. Gene Ther.
, vol.14
, pp. 191-202
-
-
Anderson, D.M.1
-
103
-
-
78049475611
-
mRNA transfection of cervical carcinoma and mesenchymal stem cells mediated by cationic carriers
-
Rejman, J., Tavernier, G., Bavarsad, N., Demeester, J., De Smedt, S. C. mRNA transfection of cervical carcinoma and mesenchymal stem cells mediated by cationic carriers. J. Control. Release 147, 385-391 (2010).
-
(2010)
J. Control. Release
, vol.147
, pp. 385-391
-
-
Rejman, J.1
Tavernier, G.2
Bavarsad, N.3
Demeester, J.4
De Smedt, S.C.5
-
104
-
-
84975832642
-
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
-
Kranz, L. M., et al. Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. Nature 534, 396-401 (2016).
-
(2016)
Nature
, vol.534
, pp. 396-401
-
-
Kranz, L.M.1
-
105
-
-
84940720241
-
Sequence-engineered mRNA without chemical nucleoside modifications enables an effective protein therapy in large animals
-
Thess, A., et al. Sequence-engineered mRNA without chemical nucleoside modifications enables an effective protein therapy in large animals. Mol. Ther. 23, 1456-1464 (2015).
-
(2015)
Mol. Ther.
, vol.23
, pp. 1456-1464
-
-
Thess, A.1
-
106
-
-
84893531193
-
Toxicity profiling of several common RNAi-based nanomedicines: A comparative study
-
Landesman-Milo, D., Peer, D. Toxicity profiling of several common RNAi-based nanomedicines: A comparative study. Drug Deliv. Transl Res. 4, 96-103 (2014).
-
(2014)
Drug Deliv. Transl Res.
, vol.4
, pp. 96-103
-
-
Landesman-Milo, D.1
Peer, D.2
-
107
-
-
16244362066
-
Cationic lipids enhance siRNA-mediated interferon response in mice
-
Ma, Z., et al. Cationic lipids enhance siRNA-mediated interferon response in mice. Biochem. Biophys. Res. Commun. 330, 755-759 (2005).
-
(2005)
Biochem. Biophys. Res. Commun.
, vol.330
, pp. 755-759
-
-
Ma, Z.1
-
108
-
-
18844457095
-
Mechanisms of type-I-A nd type-II-interferon-mediated signalling
-
Platanias, L. C. Mechanisms of type-I-A nd type-II-interferon-mediated signalling. Nat. Rev. Immunol. 5, 375-386 (2005).
-
(2005)
Nat. Rev. Immunol.
, vol.5
, pp. 375-386
-
-
Platanias, L.C.1
-
109
-
-
33746438424
-
Toxicity of cationic lipids and cationic polymers in gene delivery
-
Lv, H., Zhang, S., Wang, B., Cui, S., Yan, J. Toxicity of cationic lipids and cationic polymers in gene delivery. J. Control. Release 114, 100-109 (2006).
-
(2006)
J. Control. Release
, vol.114
, pp. 100-109
-
-
Lv, H.1
Zhang, S.2
Wang, B.3
Cui, S.4
Yan, J.5
-
110
-
-
80052233389
-
Endosome maturation
-
Huotari, J., Helenius, A. Endosome maturation. EMBO J. 30, 3481-3500 (2011).
-
(2011)
EMBO J.
, vol.30
, pp. 3481-3500
-
-
Huotari, J.1
Helenius, A.2
-
111
-
-
84872547866
-
Synthesis, characterization, and evaluation of ionizable lysine-based Lipids for siRNA delivery
-
Walsh, C. L., Nguyen, J., Tiffany, M. R., Szoka, F. C. Synthesis, characterization, and evaluation of ionizable lysine-based Lipids for siRNA delivery. Bioconjug. Chem. 24, 36-43 (2013).
-
(2013)
Bioconjug. Chem.
, vol.24
, pp. 36-43
-
-
Walsh, C.L.1
Nguyen, J.2
Tiffany, M.R.3
Szoka, F.C.4
-
112
-
-
0029964866
-
Mechanism of oligonucleotide release from cationic liposomes
-
Zelphati, O., Szoka, F. Mechanism of oligonucleotide release from cationic liposomes. Proc. Natl Acad. Sci. USA 93, 11493-11498 (1996).
-
(1996)
Proc. Natl Acad. Sci. USA
, vol.93
, pp. 11493-11498
-
-
Zelphati, O.1
Szoka, F.2
-
113
-
-
0034882516
-
On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids
-
Hafez, I. M., Maurer, N., Cullis, P. R. On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids. Gene Ther. 8, 1188-1196 (2001).
-
(2001)
Gene Ther.
, vol.8
, pp. 1188-1196
-
-
Hafez, I.M.1
Maurer, N.2
Cullis, P.R.3
-
114
-
-
84865079107
-
Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo
-
Jayaraman, M., et al. Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo. Angew. Chem. Int. Ed. 51, 8529-8533 (2012).
-
(2012)
Angew. Chem. Int. Ed.
, vol.51
, pp. 8529-8533
-
-
Jayaraman, M.1
-
115
-
-
84903643579
-
Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity
-
Whitehead, K. A., et al. Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity. Nat. Commun 5, 4277 (2014).
-
(2014)
Nat. Commun
, vol.5
, pp. 4277
-
-
Whitehead, K.A.1
-
116
-
-
84975686883
-
The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery
-
Cheng, X., Lee, R. J. The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery. Adv. Drug Deliv. Rev. 99, 129-137 (2016).
-
(2016)
Adv. Drug Deliv. Rev.
, vol.99
, pp. 129-137
-
-
Cheng, X.1
Lee, R.J.2
-
117
-
-
33847099637
-
Lipid-based nanoparticles for nucleic acid delivery
-
Li, W., Szoka, F. C. Jr. Lipid-based nanoparticles for nucleic acid delivery. Pharm. Res. 24, 438-449 (2007).
-
(2007)
Pharm. Res.
, vol.24
, pp. 438-449
-
-
Li, W.1
Szoka, F.C.2
-
118
-
-
79959971282
-
Nanoparticle PEGylation for imaging and therapy
-
Jokerst, J. V., Lobovkina, T., Zare, R. N., Gambhir, S. S. Nanoparticle PEGylation for imaging and therapy. Nanomedicine 6, 715-728 (2011).
-
(2011)
Nanomedicine
, vol.6
, pp. 715-728
-
-
Jokerst, J.V.1
Lobovkina, T.2
Zare, R.N.3
Gambhir, S.S.4
-
119
-
-
84946962398
-
Optimization of lipid nanoparticle formulations for mRNA delivery in vivo with fractional factorial and definitive screening designs
-
Kauffman, K. J., et al. Optimization of lipid nanoparticle formulations for mRNA delivery in vivo with fractional factorial and definitive screening designs. Nano Lett. 15, 7300-7306 (2015).
-
(2015)
Nano Lett.
, vol.15
, pp. 7300-7306
-
-
Kauffman, K.J.1
-
120
-
-
0031872180
-
Characterization of lipid DNA interactions. I. Destabilization of bound lipids and DNA dissociation
-
Harvie, P., Wong, F., Bally, M. Characterization of lipid DNA interactions. I. Destabilization of bound lipids and DNA dissociation. Biophys. J. 75, 1040-1051 (1998).
-
(1998)
Biophys. J.
, vol.75
, pp. 1040-1051
-
-
Harvie, P.1
Wong, F.2
Bally, M.3
-
121
-
-
84975780726
-
Bioinspired alkenyl amino alcohol ionizable lipid materials for highly potent in vivo mRNA delivery
-
Fenton, O. S., et al. Bioinspired alkenyl amino alcohol ionizable lipid materials for highly potent in vivo mRNA delivery. Adv. Mater 28, 2939-2943 (2016).
-
(2016)
Adv. Mater
, vol.28
, pp. 2939-2943
-
-
Fenton, O.S.1
-
122
-
-
84945466813
-
Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes
-
Pardi, N., et al. Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes. J. Control. Release 217, 345-351 (2015).
-
(2015)
J. Control. Release
, vol.217
, pp. 345-351
-
-
Pardi, N.1
-
123
-
-
85015230578
-
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
-
Pardi, N., et al. Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination. Nature 543, 248-251 (2017).
-
(2017)
Nature
, vol.543
, pp. 248-251
-
-
Pardi, N.1
-
124
-
-
85013067893
-
Modified mRNA vaccines protect against Zika virus infection
-
Richner, J. M., et al. Modified mRNA vaccines protect against Zika virus infection. Cell 168, 1114-1125 (2017).
-
(2017)
Cell
, vol.168
, pp. 1114-1125
-
-
Richner, J.M.1
-
125
-
-
85018162127
-
Preclinical and clinical demonstration of immunogenicity by mRNA vaccines against H10N8 and H7N9 influenza viruses
-
Bahl, K., et al. Preclinical and clinical demonstration of immunogenicity by mRNA vaccines against H10N8 and H7N9 influenza viruses. Mol. Ther. 25, 1316-1327 (2017).
-
(2017)
Mol. Ther.
, vol.25
, pp. 1316-1327
-
-
Bahl, K.1
-
126
-
-
84960882884
-
Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo
-
Yin, H., et al. Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo. Nat. Biotechnol 34, 328-333 (2016).
-
(2016)
Nat. Biotechnol
, vol.34
, pp. 328-333
-
-
Yin, H.1
-
127
-
-
85007325110
-
Non-viral CRISPR/Cas gene editing in vitro and in vivo enabled by synthetic nanoparticle co-delivery of Cas9 mRNA and sgRNA
-
Miller, J. B., et al. Non-viral CRISPR/Cas gene editing in vitro and in vivo enabled by synthetic nanoparticle co-delivery of Cas9 mRNA and sgRNA. Angew. Chem. Int. Ed. 56, 1059-1063 (2017).
-
(2017)
Angew. Chem. Int. Ed.
, vol.56
, pp. 1059-1063
-
-
Miller, J.B.1
-
128
-
-
85010919122
-
A non-viral CRISPR/Cas9 delivery system for therapeutically targeting HBV DNA and pcsk9 in vivo
-
Jiang, C., et al. A non-viral CRISPR/Cas9 delivery system for therapeutically targeting HBV DNA and pcsk9 in vivo. Cell Res. 27, 440-443 (2017).
-
(2017)
Cell Res.
, vol.27
, pp. 440-443
-
-
Jiang, C.1
-
129
-
-
19744372388
-
Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis
-
Akinc, A., Thomas, M., Klibanov, A. M., Langer, R. Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis. J. Gene Med. 7, 657-663 (2004).
-
(2004)
J. Gene Med.
, vol.7
, pp. 657-663
-
-
Akinc, A.1
Thomas, M.2
Klibanov, A.M.3
Langer, R.4
-
130
-
-
0029160083
-
A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine
-
Boussif, O., Lezoualch, F., Zanta, M. A., Mergny, M. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine. Proc. Natl Acad. Sci. USA 92, 7297-7301 (1995).
-
(1995)
Proc. Natl Acad. Sci. USA
, vol.92
, pp. 7297-7301
-
-
Boussif, O.1
Lezoualch, F.2
Zanta, M.A.3
Mergny, M.4
-
131
-
-
20444377785
-
Polyethylenimine-based non-viral gene delivery systems
-
Lungwitz, U., Breunig, M., Blunk, T., Göpferich, A. Polyethylenimine-based non-viral gene delivery systems. Eur. J. Pharm. Biopharm. 60, 247-266 (2005).
-
(2005)
Eur. J. Pharm. Biopharm.
, vol.60
, pp. 247-266
-
-
Lungwitz, U.1
Breunig, M.2
Blunk, T.3
Göpferich, A.4
-
132
-
-
84961595277
-
Enhanced intranasal delivery of mRNA vaccine by overcoming the nasal epithelial barrier via intra-A nd paracellular pathways
-
Li, M., et al. Enhanced intranasal delivery of mRNA vaccine by overcoming the nasal epithelial barrier via intra-A nd paracellular pathways. J. Control. Release 228, 9-19 (2016).
-
(2016)
J. Control. Release
, vol.228
, pp. 9-19
-
-
Li, M.1
-
133
-
-
85006931080
-
Self-aggregating 1.8 kDa polyethylenimines with dissolution switch at endosomal acidic pH are delivery carriers for plasmid DNA, mRNA, siRNA and exon-skipping oligonucleotides
-
Chiper, M., Tounsi, N., Kole, R., Kichler, A., Zuber, G. Self-aggregating 1.8 kDa polyethylenimines with dissolution switch at endosomal acidic pH are delivery carriers for plasmid DNA, mRNA, siRNA and exon-skipping oligonucleotides. J. Control. Release 246, 60-70 (2017).
-
(2017)
J. Control. Release
, vol.246
, pp. 60-70
-
-
Chiper, M.1
Tounsi, N.2
Kole, R.3
Kichler, A.4
Zuber, G.5
-
134
-
-
84921464229
-
Treatment of neurological disorders by introducing mRNA in vivo using polyplex nanomicelles
-
Baba, M., Itaka, K., Kondo, K., Yamasoba, T., Kataoka, K. Treatment of neurological disorders by introducing mRNA in vivo using polyplex nanomicelles. J. Control. Release 201, 41-48 (2015).
-
(2015)
J. Control. Release
, vol.201
, pp. 41-48
-
-
Baba, M.1
Itaka, K.2
Kondo, K.3
Yamasoba, T.4
Kataoka, K.5
-
135
-
-
84945930982
-
Messenger RNA-based therapeutics for the treatment of apoptosis-associated diseases
-
Matsui, A., Uchida, S., Ishii, T., Itaka, K., Kataoka, K. Messenger RNA-based therapeutics for the treatment of apoptosis-associated diseases. Sci. Rep. 5, 15810 (2015).
-
(2015)
Sci. Rep.
, vol.5
, pp. 15810
-
-
Matsui, A.1
Uchida, S.2
Ishii, T.3
Itaka, K.4
Kataoka, K.5
-
136
-
-
84953276749
-
Messenger RNA delivery of a cartilage-anabolic transcription factor as a disease-modifying strategy for osteoarthritis treatment
-
Aini, H., et al. Messenger RNA delivery of a cartilage-anabolic transcription factor as a disease-modifying strategy for osteoarthritis treatment. Sci. Rep. 6, 18743 (2016).
-
(2016)
Sci. Rep.
, vol.6
, pp. 18743
-
-
Aini, H.1
-
137
-
-
85016330478
-
A targeted and stable polymeric nanoformulation enhances systemic delivery of mRNA to tumours
-
Chen, Q., et al. A targeted and stable polymeric nanoformulation enhances systemic delivery of mRNA to tumours. Mol. Ther. 25, 92-101 (2017).
-
(2017)
Mol. Ther.
, vol.25
, pp. 92-101
-
-
Chen, Q.1
-
138
-
-
84958091432
-
Poly(glycoamidoamine) brushes formulated nanomaterials for systemic siRNA and mRNA delivery in vivo
-
Dong, Y., et al. Poly(glycoamidoamine) brushes formulated nanomaterials for systemic siRNA and mRNA delivery in vivo. Nano Lett. 16, 842-848 (2016).
-
(2016)
Nano Lett.
, vol.16
, pp. 842-848
-
-
Dong, Y.1
-
139
-
-
85006869155
-
Polymer-lipid nanoparticles for systemic delivery of mRNA to the lungs
-
Kaczmarek, J. C., et al. Polymer-lipid nanoparticles for systemic delivery of mRNA to the lungs. Angew. Chem. Int. Ed. 128, 14012-14016 (2016).
-
(2016)
Angew. Chem. Int. Ed.
, vol.128
, pp. 14012-14016
-
-
Kaczmarek, J.C.1
-
140
-
-
84978919993
-
Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose
-
Chahal, J. S., et al. Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose. Proc. Natl Acad. Sci. USA 113, E4133-E4142 (2016).
-
(2016)
Proc. Natl Acad. Sci. USA
, vol.113
, pp. E4133-E4142
-
-
Chahal, J.S.1
-
141
-
-
85011003733
-
Charge-altering releasable transporters (CARTs) for the delivery and release of mRNA in living animals
-
McKinlay, C. J., et al. Charge-altering releasable transporters (CARTs) for the delivery and release of mRNA in living animals. Proc. Natl Acad. Sci. USA 114, E448-E456 (2017).
-
(2017)
Proc. Natl Acad. Sci. USA
, vol.114
, pp. E448-E456
-
-
McKinlay, C.J.1
-
142
-
-
84978075334
-
A single methylene group in oligoalkylamine-based cationic polymers and lipids promotes enhanced mRNA delivery
-
Jarzçbińska, A., et al. A single methylene group in oligoalkylamine-based cationic polymers and lipids promotes enhanced mRNA delivery. Angew. Chem. Int. Ed. 55, 9591-9595 (2016).
-
(2016)
Angew. Chem. Int. Ed.
, vol.55
, pp. 9591-9595
-
-
Jarzçbińska, A.1
-
143
-
-
84984788004
-
Transcript-activated collagen matrix as sustained mRNA delivery system for bone regeneration
-
Badieyan, Z. S., et al. Transcript-activated collagen matrix as sustained mRNA delivery system for bone regeneration. J. Control. Release 239, 137-148 (2016).
-
(2016)
J. Control. Release
, vol.239
, pp. 137-148
-
-
Badieyan, Z.S.1
-
144
-
-
85007418165
-
Modified mRNA for BMP-2 in combination with biomaterials serves as a transcript-activated matrix for effectively inducing osteogenic pathways in stem cells
-
Balmayor, E. R., et al. Modified mRNA for BMP-2 in combination with biomaterials serves as a transcript-activated matrix for effectively inducing osteogenic pathways in stem cells. Stem Cells Dev. 26, 25-34 (2017).
-
(2017)
Stem Cells Dev.
, vol.26
, pp. 25-34
-
-
Balmayor, E.R.1
-
145
-
-
84973891011
-
Efficient mRNA delivery with graphene oxide-polyethylenimine for generation of footprint-free human induced pluripotent stem cells
-
Choi, H. Y., et al. Efficient mRNA delivery with graphene oxide-polyethylenimine for generation of footprint-free human induced pluripotent stem cells. J. Control. Release 235, 222-235 (2016).
-
(2016)
J. Control. Release
, vol.235
, pp. 222-235
-
-
Choi, H.Y.1
-
146
-
-
85016414588
-
Structurally programmed assembly of translation initiation nanoplex for superior mRNA delivery
-
Li, J., et al. Structurally programmed assembly of translation initiation nanoplex for superior mRNA delivery. ACS Nano 11, 2531-2544 (2017).
-
(2017)
ACS Nano
, vol.11
, pp. 2531-2544
-
-
Li, J.1
-
147
-
-
84900329958
-
Single-cell mRNA transfection studies: Delivery, kinetics and statistics by numbers
-
Leonhardt, C., et al. Single-cell mRNA transfection studies: Delivery, kinetics and statistics by numbers. Nanomedicine 10, 679-688 (2014).
-
(2014)
Nanomedicine
, vol.10
, pp. 679-688
-
-
Leonhardt, C.1
-
148
-
-
33846504706
-
A 'silent' polymorphism in MDR1 gene changes substrate specificity
-
Kimchi-Sarfaty, C., et al. A 'silent' polymorphism in MDR1 gene changes substrate specificity. Science 315, 525-528 (2007).
-
(2007)
Science
, vol.315
, pp. 525-528
-
-
Kimchi-Sarfaty, C.1
-
149
-
-
77951734603
-
A role for codon order in translation dynamics
-
Cannarozzi, G., et al. A role for codon order in translation dynamics. Cell 141, 355-367 (2010).
-
(2010)
Cell
, vol.141
, pp. 355-367
-
-
Cannarozzi, G.1
-
150
-
-
0027991544
-
In vitro transcription: Preparative RNA yields in analytical scale reactions
-
Pokrovskaya, I., Gurevich, V. In vitro transcription: Preparative RNA yields in analytical scale reactions. Anal. Biochem. 220, 420-423 (1994).
-
(1994)
Anal. Biochem.
, vol.220
, pp. 420-423
-
-
Pokrovskaya, I.1
Gurevich, V.2
-
151
-
-
85029293111
-
-
Moderna Therapeutics Moderna [online]
-
Moderna Therapeutics. Moderna Provides Pipeline and Full-Year Corporate Update. Moderna [online], https://www.modernatx.com/newsroom/press-releases/moderna-provides-pipeline-and-full-year-corporate-update (2017).
-
(2017)
Moderna Provides Pipeline and Full-Year Corporate Update
-
-
-
152
-
-
36949088975
-
An unstable intermediate carrying information from genes to ribosomes for protein synthesis
-
Brenner, S., Jacob, F., Meselson, M. An unstable intermediate carrying information from genes to ribosomes for protein synthesis. Nature 180, 576-581 (1961).
-
(1961)
Nature
, vol.180
, pp. 576-581
-
-
Brenner, S.1
Jacob, F.2
Meselson, M.3
-
153
-
-
0014668349
-
The synthesis of mouse hemoglobin beta-chains in a rabbit reticulocyte cell-free system programmed with mouse reticulocyte 9S RNA
-
Lockard, R. E., Lingrel, J. B. The synthesis of mouse hemoglobin beta-chains in a rabbit reticulocyte cell-free system programmed with mouse reticulocyte 9S RNA. Biochem. Biophys. Res. Commun. 37, 204-212 (1969).
-
(1969)
Biochem. Biophys. Res. Commun.
, vol.37
, pp. 204-212
-
-
Lockard, R.E.1
Lingrel, J.B.2
-
154
-
-
0018124416
-
Translation of rabbit globin mRNA introduced by liposomes into mouse lymphocytes
-
Dimitriadis, G. Translation of rabbit globin mRNA introduced by liposomes into mouse lymphocytes. Nature 274, 923-924 (1978). This is the first report of mRNA delivery using liposomes.
-
(1978)
Nature
, vol.274
, pp. 923-924
-
-
Dimitriadis, G.1
-
155
-
-
0033231048
-
RNA melanoma vaccine: Induction of antitumour immunity by human glycoprotein 100 mRNA immunization
-
Zhou, W. Z., et al. RNA melanoma vaccine: Induction of antitumour immunity by human glycoprotein 100 mRNA immunization. Hum. Gene Ther. 10, 2719-2724 (1999).
-
(1999)
Hum. Gene Ther.
, vol.10
, pp. 2719-2724
-
-
Zhou, W.Z.1
-
156
-
-
0036167308
-
Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumours
-
Heiser, A., et al. Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumours. J. Clin. Invest. 109, 409-417 (2002).
-
(2002)
J. Clin. Invest.
, vol.109
, pp. 409-417
-
-
Heiser, A.1
-
157
-
-
44949155482
-
Heritable targeted gene disruption in zebrafish using designed zinc-finger nucleases
-
Doyon, Y., et al. Heritable targeted gene disruption in zebrafish using designed zinc-finger nucleases. Nat. Biotechnol. 26, 702-708 (2008).
-
(2008)
Nat. Biotechnol.
, vol.26
, pp. 702-708
-
-
Doyon, Y.1
-
158
-
-
67349189462
-
Adoptive immunotherapy using human peripheral blood lymphocytes transferred with RNA encoding Her-2/neu-specific chimeric immune receptor in ovarian cancer xenograft model
-
Yoon, S. H., et al. Adoptive immunotherapy using human peripheral blood lymphocytes transferred with RNA encoding Her-2/neu-specific chimeric immune receptor in ovarian cancer xenograft model. Cancer Gene Ther. 16, 489-497 (2009).
-
(2009)
Cancer Gene Ther.
, vol.16
, pp. 489-497
-
-
Yoon, S.H.1
-
159
-
-
79960558872
-
Targeted genome editing across species using ZFNs and TALENs
-
Wood, A. J., et al. Targeted genome editing across species using ZFNs and TALENs. Science 333, 307-307 (2011).
-
(2011)
Science
, vol.333
, pp. 307
-
-
Wood, A.J.1
-
160
-
-
84874617789
-
Efficient genome editing in zebrafish using a CRISPR-Cas system
-
Hwang, W. Y., et al. Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat. Biotechnol. 31, 227-229 (2013).
-
(2013)
Nat. Biotechnol.
, vol.31
, pp. 227-229
-
-
Hwang, W.Y.1
-
161
-
-
84899631361
-
Antibody-modified T cells: CARs take the front seat for hematologic malignancies
-
Maus, M., Grupp, S. A., Porter, D. L., June, C. H. Antibody-modified T cells: CARs take the front seat for hematologic malignancies. Blood 123, 2625-2635 (2014).
-
(2014)
Blood
, vol.123
, pp. 2625-2635
-
-
Maus, M.1
Grupp, S.A.2
Porter, D.L.3
June, C.H.4
-
162
-
-
85010960715
-
Dual-functional lipid-like nanoparticles for delivery of mRNA and MRI contrast agents
-
Luo, X., et al. Dual-functional lipid-like nanoparticles for delivery of mRNA and MRI contrast agents. Nanoscale 9, 1575-1579 (2017).
-
(2017)
Nanoscale
, vol.9
, pp. 1575-1579
-
-
Luo, X.1
-
163
-
-
84930947142
-
In vivo genome editing using nuclease-encoding mRNA corrects SP-B deficiency
-
Mahiny, A. J., et al. In vivo genome editing using nuclease-encoding mRNA corrects SP-B deficiency. Nat. Biotechnol. 33, 584-586 (2015).
-
(2015)
Nat. Biotechnol.
, vol.33
, pp. 584-586
-
-
Mahiny, A.J.1
-
164
-
-
84973861994
-
Messenger RNA-based therapeutics for brain diseases: An animal study for augmenting clearance of -amyloid by intracerebral administration of neprilysin mRNA loaded in polyplex nanomicelles
-
Lin, C.-Y., et al. Messenger RNA-based therapeutics for brain diseases: An animal study for augmenting clearance of -amyloid by intracerebral administration of neprilysin mRNA loaded in polyplex nanomicelles. J. Control. Release 235, 268-275 (2016).
-
(2016)
J. Control. Release
, vol.235
, pp. 268-275
-
-
Lin, C.-Y.1
|